139 related articles for article (PubMed ID: 1705551)
1. Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. Evidence that the binding protein is vitronectin.
Owensby DA; Morton PA; Wun TC; Schwartz AL
J Biol Chem; 1991 Mar; 266(7):4334-40. PubMed ID: 1705551
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.
Preissner KT; Grulich-Henn J; Ehrlich HJ; Declerck P; Justus C; Collen D; Pannekoek H; Müller-Berghaus G
J Biol Chem; 1990 Oct; 265(30):18490-8. PubMed ID: 1698787
[TBL] [Abstract][Full Text] [Related]
3. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
Kost C; Stüber W; Ehrlich HJ; Pannekoek H; Preissner KT
J Biol Chem; 1992 Jun; 267(17):12098-105. PubMed ID: 1376317
[TBL] [Abstract][Full Text] [Related]
4. Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin.
Seiffert D; Mimuro J; Schleef RR; Loskutoff DJ
Cell Differ Dev; 1990 Dec; 32(3):287-92. PubMed ID: 1711915
[TBL] [Abstract][Full Text] [Related]
5. Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.
Wun TC; Palmier MO; Siegel NR; Smith CE
J Biol Chem; 1989 May; 264(14):7862-8. PubMed ID: 2470735
[TBL] [Abstract][Full Text] [Related]
6. Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.
Seiffert D; Wagner NN; Loskutoff DJ
J Cell Biol; 1990 Sep; 111(3):1283-91. PubMed ID: 1697297
[TBL] [Abstract][Full Text] [Related]
7. Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Modulation by plasminogen activator inhibitor type 1.
Morton PA; Owensby DA; Sobel BE; Schwartz AL
J Biol Chem; 1989 May; 264(13):7228-35. PubMed ID: 2540181
[TBL] [Abstract][Full Text] [Related]
8. Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells.
Mimuro J; Loskutoff DJ
J Biol Chem; 1989 Mar; 264(9):5058-63. PubMed ID: 2494180
[TBL] [Abstract][Full Text] [Related]
9. Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2.
Owensby DA; Morton PA; Schwartz AL
J Biol Chem; 1989 Oct; 264(30):18180-7. PubMed ID: 2553701
[TBL] [Abstract][Full Text] [Related]
10. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
Ehrlich HJ; Gebbink RK; Preissner KT; Keijer J; Esmon NL; Mertens K; Pannekoek H
J Cell Biol; 1991 Dec; 115(6):1773-81. PubMed ID: 1721912
[TBL] [Abstract][Full Text] [Related]
11. Differential mechanisms targeting type 1 plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line.
Hill SA; Shaughnessy SG; Joshua P; Ribau J; Austin RC; Podor TJ
Blood; 1996 Jun; 87(12):5061-73. PubMed ID: 8652819
[TBL] [Abstract][Full Text] [Related]
12. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin.
Arroyo De Prada N; Schroeck F; Sinner EK; Muehlenweg B; Twellmeyer J; Sperl S; Wilhelm OG; Schmitt M; Magdolen V
Eur J Biochem; 2002 Jan; 269(1):184-92. PubMed ID: 11784312
[TBL] [Abstract][Full Text] [Related]
13. Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin.
Seiffert D; Loskutoff DJ
J Biol Chem; 1991 Feb; 266(5):2824-30. PubMed ID: 1704366
[TBL] [Abstract][Full Text] [Related]
14. The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor.
Seiffert D; Ciambrone G; Wagner NV; Binder BR; Loskutoff DJ
J Biol Chem; 1994 Jan; 269(4):2659-66. PubMed ID: 7507927
[TBL] [Abstract][Full Text] [Related]
15. Identification of and partial characterization of platelet vitronectin: evidence for complex formation with platelet-derived plasminogen activator inhibitor-1.
Preissner KT; Holzhüter S; Justus C; Müller-Berghaus G
Blood; 1989 Nov; 74(6):1989-96. PubMed ID: 2478218
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis.
Lawrence DA; Palaniappan S; Stefansson S; Olson ST; Francis-Chmura AM; Shore JD; Ginsburg D
J Biol Chem; 1997 Mar; 272(12):7676-80. PubMed ID: 9065424
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritis.
Huang Y; Border WA; Lawrence DA; Noble NA
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F1045-54. PubMed ID: 19625379
[TBL] [Abstract][Full Text] [Related]
18. uPA binding to PAI-1 induces corneal myofibroblast differentiation on vitronectin.
Wang L; Ly CM; Ko CY; Meyers EE; Lawrence DA; Bernstein AM
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4765-75. PubMed ID: 22700714
[TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor.
Mimuro J; Schleef RR; Loskutoff DJ
Blood; 1987 Sep; 70(3):721-8. PubMed ID: 3113515
[TBL] [Abstract][Full Text] [Related]
20. Intra- and extracellular plasminogen activator inhibitor-1 regulate effect of vitronectin against radiation-induced endothelial cell death.
Hazawa M; Yasuda T; Saotome-Nakamura A; Tomiyama K; Obara C; Goto T; Tajima K
Vascul Pharmacol; 2016 Dec; 87():150-158. PubMed ID: 27650166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]